Joint Formulary & PAD

Allopurinol - Inflammatory bowel disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Tablets
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important
Off-label use in combination with azathioprine and mercaptopurine

PAD Profile

ChemicalSubstance :
Allopurinol
Indication :
Inflammatory bowel disease
Group Name :
Keywords :
thiopurine, 6MP, IBD, UC, Ulcerative Colitis, Crohn's Disease
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
3

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)

Other Indications

Below are listed other indications that Allopurinol is used to treat.